DAG1 and neoplasm: Coupled with the post-translational alterations to dystroglycan; both hypo-glycosylation of α-dystroglycan and phosphorylation and proteolysis of β-dystroglycan13, are the more recent findings that β-dystroglycan is present in the nucleus of both normal and tumour cell lines14, 15, 16.